Prelude Capital Management’s Akcea Therapeutics, Inc. Common Stock AKCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-30,618
Closed -$555K 1831
2020
Q3
$555K Buy
+30,618
New +$555K 0.03% 267